Antiviral Treatment
-
{
- All
- News
- Videos
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
How Nipah Virus Overwhelms The Immune System And Turns It Against The Body
Nipah virus does not just infect the body, it disrupts immune defences at multiple levels, suppressing early antiviral responses and triggering harmful inflammation.
-
What Is Nipah Virus And Its Symptoms?
Nipah virus infections can lead to respiratory distress, encephalitis (brain inflammation), and even death. As there is currently no specific treatment or vaccine for this virus, early detection and preventive measures are crucial to controlling its spread.
-
Understanding The Difference Between HMPV And RSV Respiratory Infections
HMPV Infection Vs. RSV Infection: Understanding the differences between HMPV and RSV is crucial for timely diagnosis, prevention, and management.
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
-
Can Antibodies From Camels Help Develop Dengue Vaccines? Researchers From Mohali Reveal
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "nanobodies" could pave the way for future dengue tr
-
How Nipah Virus Overwhelms The Immune System And Turns It Against The Body
Nipah virus does not just infect the body, it disrupts immune defences at multiple levels, suppressing early antiviral responses and triggering harmful inflammation.
-
What Is Nipah Virus And Its Symptoms?
Nipah virus infections can lead to respiratory distress, encephalitis (brain inflammation), and even death. As there is currently no specific treatment or vaccine for this virus, early detection and preventive measures are crucial to controlling its spread.
-
Understanding The Difference Between HMPV And RSV Respiratory Infections
HMPV Infection Vs. RSV Infection: Understanding the differences between HMPV and RSV is crucial for timely diagnosis, prevention, and management.
-
Baby's Dark-Brown Eyes Turn Blue After Covid-19 Treatment In Thailand: Report
The dark brown eyes of a 6-month-old infant in Thailand temporarily turned indigo blue after receiving a common COVID-19 treatment.
-
Covid Pill Shows Rapid Clearance Of Virus, Says Japan Pharma Firm
An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday.
-
Positive Results In Phase 3 Trial Of Covid Pill, Says Hetero Pharma Group
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Opinion: Deciding Who Should Get The Covid Pill Will Be Tough
Scientists who've been reluctant to talk up any new Covid-19 treatment are suddenly using the expression "game changer" to describe the Pfizer antiviral pill Paxlovid. But the changed game will include rationing.
-
Game-Changing Made-In-India Anti-Covid Pills Could Be Cleared For Use In Days
Emergency Use Authorisation for the Merck drug Molnupiravir -- an oral antiviral medicine for the treatment of mild-to-moderate COVID-19 -- is likely "within days", Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV today.
